Health TrialsbyHealthPanel

Whole Body Vibration in Middle Aged Men

ConditionsBone DensityMuscle Weakness
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age50+
SponsorJouf University

About this trial

This study aims of this clinical trial is to evaluate the effect of an 8-week Whole Body Vibration (WBV) intervention on Bone Mineral Density (BMD), hand grip strength, and vitamin D levels in middle-aged men. Findings from this study will contribute to understanding whether WBV is a viable alternative to conventional exercise, especially for those with limitations in physical activity.

Study Objectives:

• Primary Objective: To assess the effectiveness of an 8-week WBV intervention in improving BMD, hand grip strength, and vitamin D levels compared to a placebo intervention.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Male participants aged 50 years or older

Participants with physical activity or exercise program involvement

Participants with no history of serious medical conditions such as tumors, fractures, epilepsy, cardiac disease, or stroke within the past year.

Participants must be non-smokers and not receiving hormone or calcium supplement therapy

Disqualifiers

Participants unable to stand on the WBV platform

Participants with conditions contraindicating vibration therapy

Participants participating in other clinical trials

Trial design

Design model

Parallel

Treatments tested in this trial

  • Dynatronics VF5 Model vibration platform

    Device

    The Dynatronics VF5 Model vibration platform is a specialized therapeutic device designed for rehabilitation and wellness applications. Utilizing advanced vibration technology, it provides whole-body vibration therapy that can enhance muscle strength, improve flexibility, and promote overall physical well-being. The platform features adjustable frequency and amplitude settings, allowing customization based on individual needs. Its user-friendly interface and robust, durable design make it suitable for both clinical and mobile therapy settings. Additionally, the compact and portable nature of the VF5 facilitates easy storage and transport, while safety features such as non-slip surfaces ensure user protection.

  • Placebo Dynatronics VF5 Model vibration platform

    Device

    Placebo intensity with vertical vibration of 0.2 mm

Treatment groups

34 Participants
are divided into 2 treatment groups
Group A: Control Group with placebo vibration therapyPlacebo comparator 1 intervention
Group B: Experimental GroupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Bone Density

Changes in BMD (measured by DXA scanner),

Time frame
8 weeks
2

Grip Strength

hand grip strength (measured by a hand-held dynamometer)

Time frame
8 weeks
3

Vitamin D

Vitamin D levels (measured by high-performance liquid chromatography).

Time frame
8 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Jouf University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: